Correlation Between Kiromic Biopharma and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Regen BioPharma, you can compare the effects of market volatilities on Kiromic Biopharma and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Regen BioPharma.
Diversification Opportunities for Kiromic Biopharma and Regen BioPharma
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiromic and Regen is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Regen BioPharma go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Regen BioPharma
If you would invest 16.00 in Regen BioPharma on October 25, 2024 and sell it today you would lose (8.13) from holding Regen BioPharma or give up 50.81% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.61% |
Values | Daily Returns |
Kiromic Biopharma vs. Regen BioPharma
Performance |
Timeline |
Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Regen BioPharma |
Kiromic Biopharma and Regen BioPharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kiromic Biopharma and Regen BioPharma
The main advantage of trading using opposite Kiromic Biopharma and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
Regen BioPharma vs. Oncology Pharma | Regen BioPharma vs. Creative Medical Technology | Regen BioPharma vs. Therasense | Regen BioPharma vs. Enzolytics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |